Michael Bernard

Michael M. Bernard is a Partner at Sheridan Capital Partners, a Chicago-based healthcare-focused private equity firm founded in 2012 that invests in lower-middle-market buyouts and growth equity across the U.S. and Canada. He leads investments across the healthcare end market, with a particular emphasis on outsourced med-tech and pharma services. He was promoted to Partner as part of the firm's 2025 activity, having previously served as a Principal there.

Bernard has worked in principal investing and investment banking since 2007. Before Sheridan, he was at Riverside Partners, a middle-market private equity firm focused on healthcare and technology. Prior to that he was a Principal (and earlier Vice President) at Linden Capital Partners — the Chicago healthcare/life-sciences buyout firm behind the lindenllc.com address in the source record — which he joined in 2016 from 3i Group, where he spent two years focused on healthcare investing. He began his career at Morgan Stanley in New York, first in the leveraged-loan investment group and then in the Healthcare Investment Banking group.

He holds a BA in Economics from Brown University and an MBA in Health Enterprise Management from Northwestern University's Kellogg School of Management.

Note on the source data: the stub described him as an "Angel Investor" making "Seed Round" investments at "Linden LLC." Research does not support this. Both Linden Capital Partners and his current firm, Sheridan Capital Partners, are healthcare private-equity buyout firms; the angel/seed labeling appears to be an aggregator error, and the Linden email/phone are tied to a firm he has since left.

• Invests exclusively in healthcare and life sciences, concentrating on outsourced med-tech and pharma services — the segment he personally leads at Sheridan.
• Backs growth-driven, lower-middle-market companies (enterprise values ~$25M–$150M) through control buyouts and growth equity across the U.S. and Canada.
• Sheridan's stated approach favors businesses "that deliver clinical excellence and innovation," pairing capital with operating resources and add-on M&A to scale platforms.
• On the Currier Plastics deal, Bernard framed his thesis around backing durable customer relationships and investing to deepen them: *"Currier continues to win new business from highly demanding customers for a reason. We are excited to add even more resources to Currier so it can be the best possible partner to its customers."*